Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Malignant Neoplasms
|
1641 | 0.716 | 0.200 | 12 | 68808384 | 5 prime UTR variant | A/G | snv | 0.37 | 0.030 | 1.000 | 3 | 2016 | 2018 | |||||
Primary malignant neoplasm
|
1374 | 0.716 | 0.200 | 12 | 68808384 | 5 prime UTR variant | A/G | snv | 0.37 | 0.030 | 1.000 | 3 | 2016 | 2018 | |||||
Retinoblastoma
|
193 | 0.716 | 0.200 | 12 | 68808384 | 5 prime UTR variant | A/G | snv | 0.37 | 0.030 | 1.000 | 3 | 2016 | 2018 | |||||
Adult Liver Carcinoma
|
72 | 0.716 | 0.200 | 12 | 68808384 | 5 prime UTR variant | A/G | snv | 0.37 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Carcinoma of larynx
|
65 | 0.716 | 0.200 | 12 | 68808384 | 5 prime UTR variant | A/G | snv | 0.37 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Carcinoma of lung
|
1204 | 0.716 | 0.200 | 12 | 68808384 | 5 prime UTR variant | A/G | snv | 0.37 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Extrapulmonary Small Cell Carcinoma
|
11 | 0.716 | 0.200 | 12 | 68808384 | 5 prime UTR variant | A/G | snv | 0.37 | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||
Liver and Intrahepatic Biliary Tract Carcinoma
|
73 | 0.716 | 0.200 | 12 | 68808384 | 5 prime UTR variant | A/G | snv | 0.37 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Male infertility
|
146 | 0.716 | 0.200 | 12 | 68808384 | 5 prime UTR variant | A/G | snv | 0.37 | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||
Malignant neoplasm of liver
|
88 | 0.716 | 0.200 | 12 | 68808384 | 5 prime UTR variant | A/G | snv | 0.37 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Malignant neoplasm of lung
|
1142 | 0.716 | 0.200 | 12 | 68808384 | 5 prime UTR variant | A/G | snv | 0.37 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Malignant neoplasm of stomach
|
615 | 0.716 | 0.200 | 12 | 68808384 | 5 prime UTR variant | A/G | snv | 0.37 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Neoplasms
|
1644 | 0.716 | 0.200 | 12 | 68808384 | 5 prime UTR variant | A/G | snv | 0.37 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Primary malignant neoplasm of lung
|
981 | 0.716 | 0.200 | 12 | 68808384 | 5 prime UTR variant | A/G | snv | 0.37 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Rectal Carcinoma
|
112 | 0.716 | 0.200 | 12 | 68808384 | 5 prime UTR variant | A/G | snv | 0.37 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Squamous cell carcinoma
|
257 | 0.716 | 0.200 | 12 | 68808384 | 5 prime UTR variant | A/G | snv | 0.37 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Squamous cell carcinoma of esophagus
|
329 | 0.716 | 0.200 | 12 | 68808384 | 5 prime UTR variant | A/G | snv | 0.37 | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||
Stomach Carcinoma
|
652 | 0.716 | 0.200 | 12 | 68808384 | 5 prime UTR variant | A/G | snv | 0.37 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Tumor Cell Invasion
|
169 | 0.716 | 0.200 | 12 | 68808384 | 5 prime UTR variant | A/G | snv | 0.37 | 0.010 | 1.000 | 1 | 2016 | 2016 |